Patents by Inventor Chris Royce Rasmussen

Chris Royce Rasmussen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-?(thien-3-yl)methyl!-imidazole analgesics
    Patent number: 5750720
    Abstract: Described herein are 4-?(thien-3-yl)methyl!-imidazoles of the formula: ##STR1## wherein R is hydrogen or methyl, andX is C.sub.1-4 alkyl, bromine or chlorine; or ##STR2## wherein Y is hydrogen, C.sub.1-4 alkyl, bromine or chlorine, andZ is C.sub.1-4 4alkyl, bromine or chlorine which have exceptional analgesic activity.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: May 12, 1998
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Robert E. Boyd, Chris Royce Rasmussen, Jeffrey B. Press
  • Benzhydryl guanidines
    Patent number: 4101659
    Abstract: Benzhydryl derivatives of guanidine (Formula I) having blood sugar lowering activity; pharmaceutical hypoglycemic compositions thereof and methods of administering same to hyperglycemic individuals.
    Type: Grant
    Filed: August 29, 1977
    Date of Patent: July 18, 1978
    Assignee: McNeil Laboratories, Incorporated
    Inventor: Chris Royce Rasmussen
  • 2-Aryl-4-cyanomethyl-5-methylimidazoles
    Patent number: 4093811
    Abstract: Novel 2-aryl-4-cyanomethyl-5-methylimidazoles useful for their ultra-violet (U.V.) absorbing properties, and certain novel precursors therefor. The species, 2-cyanomethyl-5-methyl-4-phenylimidazole, also has cerebral vasodilating activity.
    Type: Grant
    Filed: June 3, 1976
    Date of Patent: June 6, 1978
    Assignee: McNeil Laboratories, Incorporated
    Inventor: Chris Royce Rasmussen
  • Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants
    Patent number: 4046909
    Abstract: Compounds of the class of 1-aryl-3-pyrrolidylidene ureas, 1-aryl-3-piperidylidene ureas and 1-aryl-3-hexahydroazepinylidene ureas, useful as central nervous system (CNS) depressants.
    Type: Grant
    Filed: July 16, 1975
    Date of Patent: September 6, 1977
    Assignee: McNeil Laboratories, Incorporated
    Inventors: Chris Royce Rasmussen, Joseph Francis Gardocki, James Nelson Plampin
  • 4-Oxo-2-hexahydropyrimidinylidene ureas
    Patent number: 4025517
    Abstract: Compounds of the class of 4-oxo-2-imidazolidinylidene ureas and 4-oxo-2-hexahydropyrimidinylidene ureas, useful as anti-secretory agents and central nervous system (CNS) depressants.
    Type: Grant
    Filed: June 7, 1976
    Date of Patent: May 24, 1977
    Assignee: McNeil Laboratories, Incorporated
    Inventor: Chris Royce Rasmussen
  • Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants
    Patent number: 3998958
    Abstract: Compounds of the class of 1-aryl-3-pyrrolidylidene ureas, 1-aryl-3-piperidylidene ureas and 1-aryl-3-hexahydroazepinylidene ureas, useful as central nervous system (CNS) depressants.
    Type: Grant
    Filed: July 16, 1975
    Date of Patent: December 21, 1976
    Assignee: McNeil Laboratories, Incorporated
    Inventors: Chris Royce Rasmussen, Joseph Francis Gardocki, James Nelson Plampin
  • 4-Oxo-2-imidazolidinylidene ureas
    Patent number: 3983135
    Abstract: Compounds of the class of 4-oxo-2-imidazolidinylidene ureas and 4-oxo-2-hexahydropyrimidinylidene ureas, useful as anti-secretory agents and central nervous system (CNS) depressants.
    Type: Grant
    Filed: June 23, 1975
    Date of Patent: September 28, 1976
    Assignee: McNeil Laboratories, Incorporated
    Inventor: Chris Royce Rasmussen
  • 2-Aryl-4-(R-methyl)-5-methylimidazoles
    Patent number: 3932445
    Abstract: 2-Aryl-5-methylimidazoles bearing various substituted methyls in the 4-position useful for their ultra-violet (U.V.) absorbing properties.
    Type: Grant
    Filed: June 26, 1974
    Date of Patent: January 13, 1976
    Assignee: McNeil Laboratories, Incorporated
    Inventor: Chris Royce Rasmussen